We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Medicines and Healthcare products Regulatory Agency’s (MHRA) Criminal Enforcement Unit (CEU) seized a quantity of suspected unlicensed medical products following coordinated raids at three residential and six business premises in Bolton, Greater Manchester.
Information for under 18s and their parents or guardians on the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021.
How practitioners and businesses can comply with the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021.
Information for local authorities, the police and others involved in enforcing the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021.
People and businesses are invited to share their views on how to make non-surgical cosmetic procedures safer as thousands complain of ‘botched’ procedures.
The symptoms and epidemiology of botulism.
The Botulinum Toxin and Cosmetic Fillers (Children) Act grant determination and allocation to local authorities in England for the financial year 2021 to 2022.
The Botulinum Toxin and Cosmetic Fillers (Children) Act grant determination and allocation to local authorities in England for the financial year 2022 to 2023.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).